NEW YORK, Sept. 27 - PerkinElmer is now one step closer to acquiring Packard BioScience after shareholders from both firms approved the deal, the companies said in a joint statement on Thursday.

The merger, announced in July and reported by GenomeWeb , still remains subject to customary closing conditions and regulatory approvals, including approval by the Federal Trade Commission.

The companies expect to tie the knot in the fourth quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.